Physician profile
James E Lynch
NPI 1114246840
$3,299.78
in general payments reported to CMS, 2019-2025
22 companies · $522 in 2025
The $522 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $490 · 2021: $190 · 2022: $692 · 2023: $835 · 2024: $228 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,559 · Education: $25.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,559.30 |
| Education | $25.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $2,346.83 | 2019-2025 | Harmonic, Echelon Endopath, Echelon; Endopath |
| Davol INC. | $280.43 | 2019-2025 | Phasix Mesh, Arista |
| W. L. Gore & Associates, INC. | $103.87 | 2023-2025 | Gore Enform Preperitoneal Biomaterial, Gore Bio-A Tissue Reinforcement |
| Abbvie INC. | $92.54 | 2023 | |
| Intuitive Surgical, INC. | $84.80 | 2023 | Da Vinci Surgical System |
| Lexington Medical, INC. | $64.66 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $49.86 | 2024-2025 | |
| Acacia Pharma INC | $49.22 | 2022 | |
| Molli Surgical (US) INC | $32.79 | 2022 | |
| Conmed Corporation | $21.90 | 2024 | Airseal |
| Smith+Nephew, INC. | $19.20 | 2021 | |
| Heron Therapeutics, INC. | $16.47 | 2023 | Aponvie |
| Convatec INC. | $15.00 | 2025 | |
| Janssen Pharmaceuticals, INC | $14.14 | 2022 | |
| Tela Bio, INC. | $14.12 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $14.05 | 2022 | |
| Polynovo North America LLC | $13.95 | 2025 | Novosorb Btm |
| Pacira Pharmaceuticals Incorporated | $13.86 | 2024 | Exparel |
| Solventum Corporation | $13.81 | 2025 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Allergan, INC. | $13.13 | 2022 | |
| Eagle Pharmaceuticals, INC. | $12.89 | 2022 | |
| Elucent Medical | $12.26 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.